Cg Oncology IncCGON
ASignal's systematic analysis rates CGON as Neutral.
Reflects the latest available analysis · analyzed Aug 26, 2026
The case on CGON
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Positive RSI reading near neutral zone (56.01) indicating room for upside
- MACD slightly above signal line with positive histogram, suggesting strengthening momentum
- Strong liquidity position with current ratio of 22.22x and quick ratio of 21.78x
- Low debt-to-equity ratio of 0.01x indicating minimal leverage risk
- Cash-rich balance sheet with $1.03B in cash against $8.82M in debt
- Extremely high valuation metrics: P/S of 1101.60x and EV/Revenue of 959.97x
- Negative operating margin (-7467.68%) and negative ROE (-26.41%)
- Negative free cash flow of $-113.71M and negative operating cash flow
- No Reddit mentions, indicating lack of retail investor interest
- Forward P/E of -25.62x suggests unprofitable earnings trajectory
- Lack of revenue and earnings growth data (N/A), common in early-stage biotech
See the full verdict on CGON
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes CGON
Most investors never get a second opinion, let alone several. ASignal runs CGON past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.